日本語 
Recruitment for this clinical study is now complete, and we are no longer accepting new participants. Thank you for your interest
Recruitment for this clinical study is now complete, and we are no longer accepting new participants. Thank you for your interest
Hermann V, Batalov A, Smakotina S, Juif PE, Cornelisse P. First use of cenerimod, a selective S1P1 receptor modulator, for the treatment of SLE: a double-blind, randomised, placebo-controlled, proof-of-concept study. Lupus Sci Med. 2019 Nov 9;6(1):e000354.